Rep. Dunn Introduces the FAIC Act to Change Medicare Payments for Cancer Drugs
The FAIC Act is currently in the early stages of the legislative process. It has been sent to two House committees for review and is waiting for further action. The bill is considered active as it moves through these initial committee assignments.
While it has support from both Republicans and Democrats, Medicare payment bills often face a long road through committees before they can get a final vote.
Medicare beneficiaries receiving cancer treatment in hospital outpatient settings could benefit from improved access to newer, expensive cancer drugs. When hospitals are reimbursed fairly for costly treatments, they are less likely to steer patients toward cheaper alternatives or refer them elsewhere. However, because the bill is budget neutral, payments for other outpatient services would be reduced to offset the higher cancer drug payments, which could affect beneficiaries receiving non-cancer outpatient care.
“the Secretary shall not package payment for such treatment into a payment for a covered OPD service (or group of services), and shall make a separate payment as specified in clause (ii) for such treatment”
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
No related news coverage found for this legislation yet.
Document Type
Congressional Bill
Official Title
FAIC Act
Analysis generated by AI. Always verify with official sources.